XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
10. Segment Information (Tables)
 3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Information regarding industry segments Information regarding industry segments for the three months ended March 31, 2018 and 2017 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2018
$
197.8

 
$
350.8

 
$
2.9

 
2017
$
174.3

 
$
322.3

 
$
3.5

 
 
 
 
 
 
 
Segment net profit (loss)
2018
$
3.3

 
$
36.6

 
$
—

 
2017
$
(18.8
)
 
$
41.6

 
$
0.2


Prior year amounts have been adjusted (see Note 1 to the condensed consolidated financial statements in regard to ASU 2017-07 for pension and other postretirement benefits).
Reconciliation of segment profit to consolidated income before taxes The following reconciles total segment profit to consolidated income before taxes (in millions):
 
Three Months Ended
 
March 31,
 
2018
 
2017
Total segment profit
$
39.9

 
$
23.0

Foreign currency exchange losses, net
(1.3
)
 
(1.8
)
Net corporate operating, interest and other expense not allocated to segments
(1.9
)
 
(2.1
)
Change in fair market value of equity securities
815.9

 
—

Other income (expense), net
11.1

 
1.0

Consolidated income before income taxes
$
863.7

 
$
20.1


Prior year amounts have been adjusted (see Note 1 to the condensed consolidated financial statements in regard to ASU 2017-07 for pension and other postretirement benefits).